Clinical Trial Update: Protease Inhibitor Vs. Raltegravir-based ART and Inflammation in HIV Infection [Phase 4]

View source ↗

Summary

Phase 4 trial comparing protease inhibitor–based ART with raltegravir-based ART in HIV infection has completed; the snippet does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Protease inhibitor-based ART
• Raltegravir-based ART

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: HIV | Phase 4 | Status: COMPLETED